Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p469 has 65 genes in the original annotation. Currently, there are 43 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
1959	EGR2	AT591 \| CMT1D \| CMT4E \| KROX20	early growth response 2	10q21.1
6688	SPI1	OF \| PU.1 \| SFPI1 \| SPI-1 \| SPI-A	Spi-1 proto-oncogene	11p11.2
7070	THY1	CD90 \| CDw90	Thy-1 cell surface antigen	11q23.3
2113	ETS1	ETS-1 \| EWSR2 \| c-ets-1 \| p54	ETS proto-oncogene 1, transcription factor	11q23.3
867	CBL	C-CBL \| CBL2 \| FRA11B \| NSLL \| RNF55	Cbl proto-oncogene, E3 ubiquitin protein ligase	11q23.3
57379	AICDA	AID \| ARP2 \| CDA2 \| HEL-S-284 \| HIGM2	activation-induced cytidine deaminase	12p13
6778	STAT6	D12S1644 \| IL-4-STAT \| STAT6B \| STAT6C	signal transducer and activator of transcription 6	12q13
6667	SP1	-	Sp1 transcription factor	12q13.1
2971	GTF3A	AP2 \| TFIIIA	general transcription factor IIIA	13q12.3-q13.1
8660	IRS2	IRS-2	insulin receptor substrate 2	13q34
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
2242	FES	FPS	FES proto-oncogene, tyrosine kinase	15q26.1
8651	SOCS1	CIS1 \| CISH1 \| JAB \| SOCS-1 \| SSI-1 \| SSI1 \| TIP3	suppressor of cytokine signaling 1	16p13.13
246	ALOX15	12-LOX \| 15-LOX-1 \| 15LOX-1	arachidonate 15-lipoxygenase	17p13.3
6776	STAT5A	MGF \| STAT5	signal transducer and activator of transcription 5A	17q11.2
6356	CCL11	SCYA11	C-C motif chemokine ligand 11	17q12
3690	ITGB3	BDPLT16 \| BDPLT2 \| CD61 \| GP3A \| GPIIIa \| GT	integrin subunit beta 3	17q21.32
2885	GRB2	ASH \| EGFRBP-GRB2 \| Grb3-3 \| MST084 \| MSTP084 \| NCKAP2	growth factor receptor bound protein 2	17q24-q25
9021	SOCS3	ATOD4 \| CIS3 \| Cish3 \| SOCS-3 \| SSI-3 \| SSI3	suppressor of cytokine signaling 3	17q25.3
3718	JAK3	JAK-3 \| JAK3_HUMAN \| JAKL \| L-JAK \| LJAK	Janus kinase 3	19p13.1
3716	JAK1	JAK1A \| JAK1B \| JTK3	Janus kinase 1	1p32.3-p31.3
2475	MTOR	FRAP \| FRAP1 \| FRAP2 \| RAFT1 \| RAPT1 \| SKS	mechanistic target of rapamycin	1p36.2
3586	IL10	CSIF \| GVHDS \| IL-10 \| IL10A \| TGIF	interleukin 10	1q31-q32
598	BCL2L1	BCL-XL/S \| BCL2L \| BCLX \| Bcl-X \| PPP1R52	BCL2 like 1	20q11.21
7033	TFF3	ITF \| P1B \| TFI	trefoil factor 3	21q22.3
3667	IRS1	HIRS-1	insulin receptor substrate 1	2q36
54625	PARP14	ARTD8 \| BAL2 \| PARP-14 \| pART8	poly(ADP-ribose) polymerase family member 14	3q21.1
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
604	BCL6	BCL5 \| BCL6A \| LAZ3 \| ZBTB27 \| ZNF51	B-cell CLL/lymphoma 6	3q27
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
3565	IL4	BCGF-1 \| BCGF1 \| BSF-1 \| BSF1 \| IL-4	interleukin 4	5q31.1
3567	IL5	EDF \| IL-5 \| TRF	interleukin 5	5q31.1
3159	HMGA1	HMG-R \| HMGA1A \| HMGIY	high mobility group AT-hook 1	6p21
4049	LTA	LT \| TNFB \| TNFSF1 \| TNLG1E	lymphotoxin alpha	6p21.3
1432	MAPK14	CSBP \| CSBP1 \| CSBP2 \| CSPB1 \| EXIP \| Mxi2 \| PRKM14 \| PRKM15 \| RK \| SAPK2A \| p38 \| p38ALPHA	mitogen-activated protein kinase 14	6p21.3-p21.2
3662	IRF4	LSIRF \| MUM1 \| NF-EM5 \| SHEP8	interferon regulatory factor 4	6p25.3
4602	MYB	Cmyb \| c-myb \| c-myb_CDS \| efg	MYB proto-oncogene, transcription factor	6q22-q23
383	ARG1	-	arginase 1	6q23
4988	OPRM1	LMOR \| M-OR-1 \| MOP \| MOR \| MOR1 \| OPRM	opioid receptor, mu 1	6q24-q25
1278	COL1A2	OI4	collagen type I alpha 2	7q22.1
3717	JAK2	JTK10 \| THCYT3	Janus kinase 2	9p24
3561	IL2RG	CD132 \| CIDX \| IL-2RG \| IMD4 \| P64 \| SCIDX \| SCIDX1	interleukin 2 receptor subunit gamma	Xq13.1
959	CD40LG	CD154 \| CD40L \| HIGM1 \| IGM \| IMD3 \| T-BAM \| TNFSF5 \| TRAP \| gp39 \| hCD40L	CD40 ligand	Xq26